| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |